Inhibitory effect of miR342 on the progression of triple-negative breast cancer cells in vitro and in the mice model

CONCLUSION: To conclude, our data support the idea that miR342 might be a potential therapeutic target for the treatment of triple-negative breast cancer (TNBC).PMID:38327636 | PMC:PMC10844590 | DOI:10.34172/bi.2023.27758

Source: BioImpacts - February 8, 2024 Category: Research Authors: Zahra Alidoost Farnoosh Attari Fatemeh Saadatpour Ehsan Arefian Source Type: research